AbbVie Inc. (ABBV) financial statements and ratios from SEC XBRL: revenue $64.4B (TTM), net margin 6.9%, revenue growth 10.2% YoY, P/E 73.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $61.16B |
| Revenue (TTM) | $64.4B |
| Net Margin | 6.9% |
| Operating Margin (TTM) | 26.2% |
| Current Ratio | 0.81 |
| Net Debt / EBITDA | 2.3 |
| Interest Coverage | 5.8 |
| Revenue Growth (YoY) | 10.2% |
| EPS Growth (YoY) | 292.3% |
| FCF Growth (YoY) | -36.2% |
| P/E Ratio | 73.7 |
| EV / EBITDA | 21.1 |
| Price / Sales | 7.22 |
| Dividend Yield | 2.6% |
| FCF Yield | 3.9% |
| Altman Z-Score | 2.57 (grey) |
| Piotroski F-Score | 7/9 |
| Piotroski checks passed | 7 of 9 |
| Industry P/E (Pharmaceutical Products) | 15.0 |
| Sector P/E (Healthcare) | 20.7 |
ABBV overview · ABBV earnings · ABBV KPIs · ABBV documents · ABBV ownership · ABBV peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.